<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en"><title>News on Nexavar</title><link href="http://liverdiseaseinfo.com/topic/nexavar" rel="alternate"></link><id>http://liverdiseaseinfo.com/topic/nexavar</id><updated>2010-11-29T15:21:22Z</updated><entry><title>Nexavar: Treatment for liver cancer</title><link href="http://liverdiseaseinfo.com/liver-diseases/nexavar-treatment-liver-cancer-4512485a" rel="alternate"></link><updated>2010-11-29T15:21:22Z</updated><author><name>Helium</name></author><id>tag:liverdiseaseinfo.com,2010-11-29:/liver-diseases/nexavar-treatment-liver-cancer-4512485a/</id><summary type="html">...</summary><category term="Cancer"></category><category term="Liver Cancer"></category><category term="Internal Medicine"></category><category term="Liver Diseases"></category><category term="Medical Treatments and Procedures"></category><category term="United States"></category><category term="New York"></category><category term="Europe"></category><category term="Wachovia Corporation"></category><category term="Food and Drug Administration"></category><category term="American Cancer Society"></category><category term="Bayer AG"></category><category term="American Society of Clinical Oncology"></category><category term="Medical Imaging and Diagnostics"></category><category term="Onyx Pharmaceuticals Inc."></category><category term="Merck Finck &amp; Co"></category><category term="Nexavar"></category><category term="Hollings Renton"></category><category term="Carsten Kunold"></category><category term="George Farmer"></category></entry><entry><title>Liver Cancer - Drug Pipeline Analysis and Market Forecasts to 2016</title><link href="http://liverdiseaseinfo.com/liver-diseases/liver-cancer-drug-pipeline-analysis-market-forecasts-2016-1189812a" rel="alternate"></link><updated>2010-09-09T19:48:08Z</updated><author><name>ArticlesBase</name></author><id>tag:liverdiseaseinfo.com,2010-09-09:/liver-diseases/liver-cancer-drug-pipeline-analysis-market-forecasts-2016-1189812a/</id><summary type="html">&lt;p&gt;&lt;a rel="nofollow" onclick="javascript:_gaq.push(['_trackPageview', '/outgoing/article_exit_link']);" href="http://www.bharatbook.com/detail.asp?id=134332&amp;amp;rt=Liver-Cancer-Drug-Pipeline-Analysis-and-Market-Forecasts-to-2016.html"&gt;Liver Cancer - Drug Pipeline Analysis and Market Forecasts to 2016 &lt;/a&gt;&lt;br /&gt;&lt;br /&gt; GlobalData, the industry analysis specialist's new report, "Liver Cancer - Drug Pipeline Analysis and Market Forecasts to 2016" is an essential source of information and analysis on...</summary><category term="Cancer"></category><category term="Liver Cancer"></category><category term="Internal Medicine"></category><category term="Liver Diseases"></category><category term="United States"></category><category term="Germany"></category><category term="Japan"></category><category term="United Kingdom"></category><category term="Italy"></category><category term="Europe"></category><category term="Spain"></category><category term="Food and Drug Administration"></category><category term="France"></category><category term="Asia"></category><category term="Western Europe"></category><category term="Bristol-Myers Squibb Company"></category><category term="Pfizer Inc."></category><category term="Twitter Inc."></category><category term="East Asia"></category><category term="Bharat Book"></category><category term="Onyx Pharmaceuticals Inc."></category><category term="F. Hoffman-La Roche Ltd."></category><category term="Southern Europe"></category><category term="Nexavar"></category><category term="Drug Association"></category><category term="Kowa Co. Ltd."></category><category term="Celsion Corporation"></category></entry><entry><title>Nexavar Data To Be Presented at 46th American Society of Clinical Oncology Annual Meeting</title><link href="http://liverdiseaseinfo.com/liver-diseases/nexavar-data-presented-46th-american-society-clinical-oncology-annual-meeting-3387234a" rel="alternate"></link><updated>2010-10-27T06:54:33Z</updated><author><name>Drugs.com</name></author><id>tag:liverdiseaseinfo.com,2010-10-27:/liver-diseases/nexavar-data-presented-46th-american-society-clinical-oncology-annual-meeting-3387234a/</id><summary type="html">...</summary><category term="Cancer"></category><category term="Breast Cancer"></category><category term="Breast Cancer Treatment"></category><category term="Kidney Cancer"></category><category term="Liver Cancer"></category><category term="Lung Cancer"></category><category term="Clinical Trials"></category><category term="Internal Medicine"></category><category term="Liver Diseases"></category><category term="Medical Treatments and Procedures"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="India"></category><category term="Texas"></category><category term="Chicago"></category><category term="Illinois"></category><category term="Germany"></category><category term="Italy"></category><category term="Europe"></category><category term="Barcelona"></category><category term="Spain"></category><category term="France"></category><category term="Asia"></category><category term="Women's Health"></category><category term="Houston (Texas)"></category><category term="Western Europe"></category><category term="Northwestern University Feinberg School of Medicine"></category><category term="M.D. Anderson Cancer Center"></category><category term="Dallas (Texas)"></category><category term="Bayer AG"></category><category term="American Society of Clinical Oncology"></category><category term="South Asia"></category><category term="Bhopal"></category><category term="Jawaharlal Nehru"></category><category term="Leverkusen"></category><category term="Rennes"></category><category term="Onyx Pharmaceuticals Inc."></category><category term="Southern Europe"></category><category term="Nexavar"></category><category term="Baylor Health Care System"></category><category term="Roy Herbst"></category><category term="Dimitris Voliotis"></category><category term="Breast Cancer Center"></category><category term="Vall d'Hebron Hospital"></category><category term="Thomas Hutson"></category><category term="Cisanello University Hospital"></category><category term="Riccardo Lencioni"></category><category term="Ted Love"></category><category term="Department of Thoracic/Head and Neck Medical Oncology"></category><category term="Jean-Luc Raoul"></category><category term="Baylor Sammons Cancer Center"></category><category term="Eugene Marquis"></category><category term="Patricia Gomez"></category><category term="Tarini Prasad Sahoo"></category><category term="William John Gradishar"></category></entry><entry><title>How Concerned Should Onyx Investors Be?</title><link href="http://liverdiseaseinfo.com/liver-diseases/concerned-onyx-investors-3372577a" rel="alternate"></link><updated>2010-10-27T06:33:29Z</updated><author><name>SeekingAlpha</name></author><id>tag:liverdiseaseinfo.com,2010-10-27:/liver-diseases/concerned-onyx-investors-3372577a/</id><summary type="html">...</summary><category term="Cancer"></category><category term="Kidney Cancer"></category><category term="Liver Cancer"></category><category term="Lung Cancer"></category><category term="Internal Medicine"></category><category term="Liver Diseases"></category><category term="United States"></category><category term="China"></category><category term="Japan"></category><category term="Europe"></category><category term="Asia"></category><category term="Bristol-Myers Squibb Company"></category><category term="Pfizer Inc."></category><category term="Avastin"></category><category term="Bayer AG"></category><category term="South Korea"></category><category term="East Asia"></category><category term="Taiwan"></category><category term="Sutent"></category><category term="Onyx Pharmaceuticals Inc."></category><category term="Nexavar"></category><category term="Torisel"></category><category term="Afinitor"></category><category term="JPMorgan Chase &amp; Co."></category><category term="Votrient"></category><category term="EvaluatePharma Ltd."></category></entry><entry><title>Bayer and Onyx Announce Nexavar Data Presentations at the Joint 15th European CanCer Organisation (ECCO) and 34th European Society for Medical Oncology (ESMO) Multidisciplinary Congress</title><link href="http://liverdiseaseinfo.com/liver-diseases/bayer-onyx-announce-nexavar-data-presentations-joint-15th-european-cancer-organisation-ecco-34th-european-society-medical-oncology-esmo-multidisciplinary-congress-3012324a" rel="alternate"></link><updated>2010-10-24T09:16:33Z</updated><author><name>Drugs.com</name></author><id>tag:liverdiseaseinfo.com,2010-10-24:/liver-diseases/bayer-onyx-announce-nexavar-data-presentations-joint-15th-european-cancer-organisation-ecco-34th-european-society-medical-oncology-esmo-multidisciplinary-congress-3012324a/</id><summary type="html">...</summary><category term="Company Activities and Information"></category><category term="Corporate Reporting"></category><category term="SEC Filings"></category><category term="Cancer"></category><category term="Kidney Cancer"></category><category term="Liver Cancer"></category><category term="Clinical Trials"></category><category term="Internal Medicine"></category><category term="Liver Diseases"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="European Union"></category><category term="Germany"></category><category term="U.S. Securities and Exchange Commission"></category><category term="Philadelphia"></category><category term="Japan"></category><category term="Europe"></category><category term="Barcelona"></category><category term="Spain"></category><category term="France"></category><category term="Asia"></category><category term="Cleveland"></category><category term="University of Heidelberg"></category><category term="Western Europe"></category><category term="Bayer AG"></category><category term="East Asia"></category><category term="Rennes"></category><category term="Onyx Pharmaceuticals Inc."></category><category term="Mainz"></category><category term="Nexavar"></category><category term="Ibaraki"></category><category term="University of Tsukuba"></category><category term="European Cancer Organisation"></category><category term="European Society for Medical Oncology"></category><category term="Dimitris Voliotis"></category><category term="Jose Baselga"></category><category term="Berlin (Germany)"></category><category term="Vall d'Hebron Hospital"></category><category term="Josep Llovet"></category><category term="Department of Otorhinolaryngology"></category><category term="Multidisciplinary Congress"></category><category term="Marcia Brose"></category><category term="Hideyuki Akaza"></category><category term="Jean-Luc Raoul"></category><category term="Joachim Beck"></category><category term="Ronald Bukowski"></category><category term="Abrahamson Cancer Center of the University of Pennsylvania"></category><category term="Cleveland Clinic Taussig Cancer Center"></category><category term="Institute of Clinical Medicine"></category><category term="National Center for Tumor Diseases"></category><category term="Ph.D. Department of Medicine"></category></entry><entry><title>UK's NICE again rejects Bayer liver cancer drug</title><link href="http://liverdiseaseinfo.com/liver-diseases/uks-nice-rejects-bayer-liver-cancer-drug-661382a" rel="alternate"></link><updated>2010-04-16T10:26:10Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:liverdiseaseinfo.com,2010-04-16:/liver-diseases/uks-nice-rejects-bayer-liver-cancer-drug-661382a/</id><summary type="html">&lt;div&gt;&lt;p&gt;LONDON (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - &lt;a title="United Kingdom" href="/topic/United+Kingdom" &gt;Britain&lt;/a&gt;'s healthcare cost-effectiveness watchdog has again rejected &lt;a title="Bayer AG" href="/topic/Bayer+AG" &gt;Bayer&lt;/a&gt;'s drug &lt;a title="Nexavar" href="/topic/Nexavar" &gt;Nexavar&lt;/a&gt; for treating liver cancer on the state health service, despite a revised charging scheme from the company.&lt;/p&gt;&lt;p&gt;Wednesday's decision is a setback for Bayer and its...</summary><category term="Cancer"></category><category term="Liver Cancer"></category><category term="Internal Medicine"></category><category term="Liver Diseases"></category><category term="United States"></category><category term="Germany"></category><category term="United Kingdom"></category><category term="Italy"></category><category term="Europe"></category><category term="Spain"></category><category term="France"></category><category term="National Institutes of Health"></category><category term="Western Europe"></category><category term="Greece"></category><category term="The Balkans"></category><category term="Bayer AG"></category><category term="Reuters Group plc"></category><category term="Romania"></category><category term="Nice (France)"></category><category term="Onyx Pharmaceuticals Inc."></category><category term="Southern Europe"></category><category term="Nexavar"></category><category term="Nicole Farmer"></category></entry><entry><title>Bayer and Onyx Announce Nexavar Data Presentations at 45th American Society of Clinical Oncology Annual Meeting</title><link href="http://liverdiseaseinfo.com/liver-diseases/bayer-onyx-announce-nexavar-data-presentations-45th-american-society-clinical-oncology-annual-meeting-3009717a" rel="alternate"></link><updated>2010-10-24T09:14:22Z</updated><author><name>Drugs.com</name></author><id>tag:liverdiseaseinfo.com,2010-10-24:/liver-diseases/bayer-onyx-announce-nexavar-data-presentations-45th-american-society-clinical-oncology-annual-meeting-3009717a/</id><summary type="html">...</summary><category term="Company Activities and Information"></category><category term="Corporate Reporting"></category><category term="SEC Filings"></category><category term="Cancer"></category><category term="Kidney Cancer"></category><category term="Leukemia"></category><category term="Liver Cancer"></category><category term="Clinical Trials"></category><category term="Internal Medicine"></category><category term="Liver Diseases"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="China"></category><category term="U.S. Securities and Exchange Commission"></category><category term="Philadelphia"></category><category term="Italy"></category><category term="Europe"></category><category term="Barcelona"></category><category term="Seattle"></category><category term="Spain"></category><category term="University of Washington"></category><category term="Netherlands"></category><category term="Asia"></category><category term="Fred Hutchinson Cancer Research Center"></category><category term="Amsterdam"></category><category term="Houston (Texas)"></category><category term="Western Europe"></category><category term="M.D. Anderson Cancer Center"></category><category term="Bayer AG"></category><category term="South Korea"></category><category term="American Society of Clinical Oncology"></category><category term="Seoul"></category><category term="East Asia"></category><category term="Milan"></category><category term="VU University Medical Center"></category><category term="Milano"></category><category term="Frankfurt Stock Exchange"></category><category term="University of Pennsylvania Health System"></category><category term="Onyx Pharmaceuticals Inc."></category><category term="Guangxi Province"></category><category term="Nanning"></category><category term="Southern Europe"></category><category term="University of Barcelona"></category><category term="Nexavar"></category><category term="First Affiliated Hospital of Guangxi Medical University"></category><category term="Ara-C"></category><category term="Department of Gastroenterology"></category><category term="Laura Brege"></category><category term="Marcia Brose"></category><category term="Jordi Bruix"></category><category term="Chul Kim"></category><category term="Shukui Qin"></category><category term="Yoon-Koo Kang"></category><category term="Department of Pulmonary Diseases"></category><category term="Farhad Ravandi"></category><category term="Giuseppe Procopio"></category><category term="Joaquim Bellmunt"></category><category term="Joline Lind"></category><category term="Mark Gelder"></category><category term="Shailender Bhatia"></category></entry><entry><title>Onyx sues Bayer over anti-cancer compound</title><link href="http://liverdiseaseinfo.com/liver-diseases/onyx-sues-bayer-anticancer-compound-527536a" rel="alternate"></link><updated>2010-04-16T12:16:42Z</updated><author><name>Reuters US Online Report Business News</name></author><id>tag:liverdiseaseinfo.com,2010-04-16:/liver-diseases/onyx-sues-bayer-anticancer-compound-527536a/</id><summary type="html">&lt;div&gt;&lt;p&gt;NEW YORK (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - &lt;a title="Onyx Pharmaceuticals Inc." href="/topic/Onyx+Pharmaceuticals+Inc." &gt;Onyx Pharmaceuticals Inc&lt;/a&gt; &amp;amp;amp;lt;ONXX.O&amp;amp;amp;gt; said on Sunday it sued &lt;a title="Bayer AG" href="/topic/Bayer+AG" &gt;Bayer AG&lt;/a&gt; &amp;amp;amp;lt;BAYG.DE&amp;amp;amp;gt; over its rights to an anti-cancer compound that it says it discovered during joint research with the German drugmaker.&lt;/p&gt;&lt;p&gt;Onyx's lawsuit, filed in the &lt;...</summary><category term="Cancer"></category><category term="Liver Cancer"></category><category term="Internal Medicine"></category><category term="Liver Diseases"></category><category term="United States"></category><category term="United Kingdom"></category><category term="Europe"></category><category term="Western Europe"></category><category term="Bayer AG"></category><category term="Reuters Group plc"></category><category term="Frankfurt"></category><category term="Onyx Pharmaceuticals Inc."></category><category term="U.S. District Court for the Northern District of California"></category><category term="Nexavar"></category><category term="Peter Dinkloh"></category><category term="Britain's National Institute of Health"></category></entry><entry><title>Nexavar Works for Liver Cancer, But It Isn&amp;#8217;t Cheap</title><link href="http://liverdiseaseinfo.com/liver-diseases/nexavar-works-liver-cancer-isn238217t-cheap-2991285a" rel="alternate"></link><updated>2010-10-23T20:54:33Z</updated><author><name>Wall Street Journal Health Blog</name></author><id>tag:liverdiseaseinfo.com,2010-10-23:/liver-diseases/nexavar-works-liver-cancer-isn238217t-cheap-2991285a/</id><summary type="html">...</summary><category term="Cancer"></category><category term="Liver Cancer"></category><category term="Internal Medicine"></category><category term="Liver Diseases"></category><category term="United States"></category><category term="China"></category><category term="Africa"></category><category term="Asia"></category><category term="The New England Journal of Medicine"></category><category term="Bayer AG"></category><category term="Sub-Saharan Africa"></category><category term="American Society of Clinical Oncology"></category><category term="East Asia"></category><category term="Nexavar"></category><category term="Josep Llovet"></category></entry><entry><title>Nexavar Works for Liver Cancer, But It Isn't Cheap</title><link href="http://liverdiseaseinfo.com/liver-diseases/nexavar-works-liver-cancer-isnt-cheap-2982799a" rel="alternate"></link><updated>2010-10-23T19:14:49Z</updated><author><name>Wall Street Journal Health Blog</name></author><id>tag:liverdiseaseinfo.com,2010-10-23:/liver-diseases/nexavar-works-liver-cancer-isnt-cheap-2982799a/</id><summary type="html">...</summary><category term="Cancer"></category><category term="Liver Cancer"></category><category term="Internal Medicine"></category><category term="Liver Diseases"></category><category term="United States"></category><category term="China"></category><category term="Africa"></category><category term="Asia"></category><category term="The New England Journal of Medicine"></category><category term="Bayer AG"></category><category term="Sub-Saharan Africa"></category><category term="American Society of Clinical Oncology"></category><category term="East Asia"></category><category term="Nexavar"></category><category term="Josep Llovet"></category></entry><entry><title>New Analyses Confirm Nexavar's Efficacy and Safety in Multiple Patient Subsets With Liver Cancer</title><link href="http://liverdiseaseinfo.com/liver-diseases/new-analyses-confirm-nexavars-efficacy-safety-multiple-patient-subsets-liver-cancer-2950114a" rel="alternate"></link><updated>2010-10-23T16:02:21Z</updated><author><name>Drugs.com</name></author><id>tag:liverdiseaseinfo.com,2010-10-23:/liver-diseases/new-analyses-confirm-nexavars-efficacy-safety-multiple-patient-subsets-liver-cancer-2950114a/</id><summary type="html">...</summary><category term="Company Activities and Information"></category><category term="Corporate Reporting"></category><category term="SEC Filings"></category><category term="Cancer"></category><category term="Liver Cancer"></category><category term="Clinical Trials"></category><category term="Internal Medicine"></category><category term="Liver Diseases"></category><category term="Medical Treatments and Procedures"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="U.S. Securities and Exchange Commission"></category><category term="Asia"></category><category term="Bayer AG"></category><category term="Frankfurt Stock Exchange"></category><category term="Onyx Pharmaceuticals Inc."></category><category term="Nexavar"></category><category term="American Association for the Study of Liver Diseases"></category><category term="Henry Fuchs"></category><category term="American Association for the Study"></category></entry><entry><title>Targeted Drug Boosts Survival Among Liver Cancer Patients</title><link href="http://liverdiseaseinfo.com/liver-diseases/targeted-drug-boosts-survival-liver-cancer-patients-2974358a" rel="alternate"></link><updated>2010-10-23T19:03:36Z</updated><author><name>EverydayHealth.com</name></author><id>tag:liverdiseaseinfo.com,2010-10-23:/liver-diseases/targeted-drug-boosts-survival-liver-cancer-patients-2974358a/</id><summary type="html">...</summary><category term="Cancer"></category><category term="Liver Cancer"></category><category term="Internal Medicine"></category><category term="Liver Diseases"></category><category term="Sexual and Reproductive Health"></category><category term="Sexually Transmitted Diseases"></category><category term="United States"></category><category term="New York City"></category><category term="Barcelona"></category><category term="American Cancer Society"></category><category term="Mayo Foundation for Medical Education and Research"></category><category term="The New England Journal of Medicine"></category><category term="Rochester"></category><category term="Mount Sinai School of Medicine"></category><category term="Bayer AG"></category><category term="Gleevec"></category><category term="Onyx Pharmaceuticals Inc."></category><category term="Nexavar"></category><category term="Lewis Roberts"></category><category term="Josep Maria Llovet"></category><category term="Jordi Bruix"></category></entry><entry><title>Bayer's Nexavar wins approval for treatment of liver cancer in China UPDATE</title><link href="http://liverdiseaseinfo.com/liver-diseases/bayers-nexavar-wins-approval-treatment-liver-cancer-china-update-2298183a" rel="alternate"></link><updated>2010-10-21T09:37:33Z</updated><author><name>Forbes</name></author><id>tag:liverdiseaseinfo.com,2010-10-21:/liver-diseases/bayers-nexavar-wins-approval-treatment-liver-cancer-china-update-2298183a/</id><summary type="html">...</summary><category term="Cancer"></category><category term="Liver Cancer"></category><category term="Internal Medicine"></category><category term="Liver Diseases"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="China"></category><category term="Asia"></category><category term="Bayer AG"></category><category term="East Asia"></category><category term="Onyx Pharmaceuticals Inc."></category><category term="The Thomson Corporation"></category><category term="Nexavar"></category></entry><entry><title>NEJM Publishes Nexavar Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer</title><link href="http://liverdiseaseinfo.com/liver-diseases/nejm-publishes-nexavar-study-demonstrating-significant-improvement-survival-patients-liver-cancer-2947864a" rel="alternate"></link><updated>2010-10-23T15:58:52Z</updated><author><name>Drugs.com</name></author><id>tag:liverdiseaseinfo.com,2010-10-23:/liver-diseases/nejm-publishes-nexavar-study-demonstrating-significant-improvement-survival-patients-liver-cancer-2947864a/</id><summary type="html">...</summary><category term="Company Activities and Information"></category><category term="Corporate Reporting"></category><category term="SEC Filings"></category><category term="Cancer"></category><category term="Liver Cancer"></category><category term="Clinical Trials"></category><category term="Internal Medicine"></category><category term="Liver Diseases"></category><category term="Medical Treatments and Procedures"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="European Union"></category><category term="New York"></category><category term="China"></category><category term="Germany"></category><category term="U.S. Securities and Exchange Commission"></category><category term="Japan"></category><category term="Europe"></category><category term="Barcelona"></category><category term="Food and Drug Administration"></category><category term="Asia"></category><category term="European Medicines Agency"></category><category term="The New England Journal of Medicine"></category><category term="Mount Sinai School of Medicine"></category><category term="Western Europe"></category><category term="Bayer AG"></category><category term="South Korea"></category><category term="American Society of Clinical Oncology"></category><category term="East Asia"></category><category term="Taiwan"></category><category term="Onyx Pharmaceuticals Inc."></category><category term="Nexavar"></category><category term="Dimitris Voliotis"></category><category term="Josep Llovet"></category></entry><entry><title>FDA Approves Eovist to Detect and Characterize Focal Liver Lesions</title><link href="http://liverdiseaseinfo.com/liver-diseases/fda-approves-eovist-detect-characterize-focal-liver-lesions-2947835a" rel="alternate"></link><updated>2010-10-23T15:58:48Z</updated><author><name>Drugs.com</name></author><id>tag:liverdiseaseinfo.com,2010-10-23:/liver-diseases/fda-approves-eovist-detect-characterize-focal-liver-lesions-2947835a/</id><summary type="html">...</summary><category term="Cancer"></category><category term="Liver Cancer"></category><category term="Internal Medicine"></category><category term="Liver Diseases"></category><category term="Medical Treatments and Procedures"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="Japan"></category><category term="Europe"></category><category term="St. Louis"></category><category term="Food and Drug Administration"></category><category term="Asia"></category><category term="American Cancer Society"></category><category term="Bayer AG"></category><category term="East Asia"></category><category term="Medical Imaging and Diagnostics"></category><category term="Nexavar"></category><category term="Jeffrey Brown"></category><category term="Body Weight"></category><category term="Douglas Stefanelli"></category></entry><entry><title>Onyx Pharmaceuticals Inc. Q1 2008 Earnings Call Transcript</title><link href="http://liverdiseaseinfo.com/liver-diseases/onyx-pharmaceuticals-q1-2008-earnings-call-transcript-2212900a" rel="alternate"></link><updated>2010-10-19T15:06:58Z</updated><author><name>SeekingAlpha</name></author><id>tag:liverdiseaseinfo.com,2010-10-19:/liver-diseases/onyx-pharmaceuticals-q1-2008-earnings-call-transcript-2212900a/</id><summary type="html">...</summary><category term="Company Activities and Information"></category><category term="Corporate Reporting"></category><category term="Earnings and Losses"></category><category term="Cancer"></category><category term="Kidney Cancer"></category><category term="Liver Cancer"></category><category term="Internal Medicine"></category><category term="Liver Diseases"></category><category term="Bayer AG"></category><category term="Onyx Pharmaceuticals Inc."></category><category term="Nexavar"></category><category term="Tony Coles"></category><category term="Hank Fuchs"></category><category term="Greg Schafer"></category><category term="Laura Brege"></category><category term="Japanese Regulatory Authorities"></category></entry><entry><title>Onyx Pharmaceuticals Inc., Q4 2007 Earnings Call Transcript</title><link href="http://liverdiseaseinfo.com/liver-diseases/onyx-pharmaceuticals-q4-2007-earnings-call-transcript-2158366a" rel="alternate"></link><updated>2010-10-19T10:01:25Z</updated><author><name>SeekingAlpha</name></author><id>tag:liverdiseaseinfo.com,2010-10-19:/liver-diseases/onyx-pharmaceuticals-q4-2007-earnings-call-transcript-2158366a/</id><summary type="html">...</summary><category term="Company Activities and Information"></category><category term="Corporate Reporting"></category><category term="Earnings and Losses"></category><category term="Cancer"></category><category term="Liver Cancer"></category><category term="Clinical Trials"></category><category term="Liver Diseases"></category><category term="Technology"></category><category term="Medical Technology"></category><category term="United States"></category><category term="European Union"></category><category term="Japan"></category><category term="Asia"></category><category term="Bayer AG"></category><category term="East Asia"></category><category term="Onyx Pharmaceuticals Inc."></category><category term="Nexavar"></category><category term="Hollings Renton"></category><category term="Hank Fuchs"></category><category term="Greg Schafer"></category><category term="Laura Brege"></category></entry><entry><title>Nexavar Approved for Liver Cancer</title><link href="http://liverdiseaseinfo.com/liver-diseases/nexavar-approved-liver-cancer-2904941a" rel="alternate"></link><updated>2010-10-23T02:53:59Z</updated><author><name>EverydayHealth.com</name></author><id>tag:liverdiseaseinfo.com,2010-10-23:/liver-diseases/nexavar-approved-liver-cancer-2904941a/</id><summary type="html">...</summary><category term="Cancer"></category><category term="Liver Cancer"></category><category term="Internal Medicine"></category><category term="Liver Diseases"></category><category term="Medical Treatments and Procedures"></category><category term="Medical Drug Therapy"></category><category term="United States"></category><category term="Food and Drug Administration"></category><category term="Centers for Disease Control and Prevention"></category><category term="Bayer AG"></category><category term="Nexavar"></category></entry><entry><title>Bayer says Nexavar approved as liver cancer treatment in U.S.</title><link href="http://liverdiseaseinfo.com/liver-diseases/bayer-nexavar-approved-liver-cancer-treatment-1300656a" rel="alternate"></link><updated>2010-09-10T12:22:24Z</updated><author><name>AP Features</name></author><id>tag:liverdiseaseinfo.com,2010-09-10:/liver-diseases/bayer-nexavar-approved-liver-cancer-treatment-1300656a/</id><summary type="html">&lt;div&gt;&lt;p&gt;Bayer's &lt;a title="Nexavar" href="/topic/Nexavar" &gt;Nexavar&lt;/a&gt; has been approved in the &lt;a title="United States" href="/topic/United+States" &gt;U.S.&lt;/a&gt; for the treatment of liver cancer, the German pharmaceutical maker said Monday.&lt;/p&gt;&lt;p&gt;The &lt;a title="Food and Drug Administration" href="/topic/Food+and+Drug+Administration" &gt;Food and Drug Administration&lt;/a&gt; extended the approval of the oral anticancer drug for the treatment of patients with the most common sort of liver cancer, Bayer said.&lt;...</summary><category term="Cancer"></category><category term="Liver Cancer"></category><category term="Internal Medicine"></category><category term="Liver Diseases"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="European Union"></category><category term="Europe"></category><category term="Food and Drug Administration"></category><category term="Bayer AG"></category><category term="Frankfurt"></category><category term="Nexavar"></category><category term="Arthur Higgins"></category></entry><entry><title>Onyx Pharmaceuticals Q3 2007 Earnings Call Transcript</title><link href="http://liverdiseaseinfo.com/liver-diseases/onyx-pharmaceuticals-q3-2007-earnings-call-transcript-2068694a" rel="alternate"></link><updated>2010-10-16T07:58:08Z</updated><author><name>SeekingAlpha</name></author><id>tag:liverdiseaseinfo.com,2010-10-16:/liver-diseases/onyx-pharmaceuticals-q3-2007-earnings-call-transcript-2068694a/</id><summary type="html">...</summary><category term="Cancer"></category><category term="Liver Cancer"></category><category term="Clinical Trials"></category><category term="Internal Medicine"></category><category term="Liver Diseases"></category><category term="Medical Treatments and Procedures"></category><category term="United States"></category><category term="European Union"></category><category term="Europe"></category><category term="European Commission"></category><category term="Asia"></category><category term="Bayer AG"></category><category term="Onyx Pharmaceuticals Inc."></category><category term="Nexavar"></category><category term="Hollings Renton"></category><category term="Hank Fuchs"></category></entry><entry><title>Onyx Pharma Flies High On Nexavar Results</title><link href="http://liverdiseaseinfo.com/liver-diseases/onyx-pharma-flies-high-nexavar-results-2001514a" rel="alternate"></link><updated>2010-10-15T09:55:26Z</updated><author><name>Forbes</name></author><id>tag:liverdiseaseinfo.com,2010-10-15:/liver-diseases/onyx-pharma-flies-high-nexavar-results-2001514a/</id><summary type="html">...</summary><category term="Financial Markets"></category><category term="Stock Prices"></category><category term="Cancer"></category><category term="Liver Cancer"></category><category term="Internal Medicine"></category><category term="Liver Diseases"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="California"></category><category term="Genentech Inc."></category><category term="Pfizer Inc."></category><category term="Avastin"></category><category term="Bayer AG"></category><category term="Sutent"></category><category term="Onyx Pharmaceuticals Inc."></category><category term="Emeryville"></category><category term="Nexavar"></category><category term="Stock Markets"></category></entry><entry><title>Breakthrough Liver Cancer Treatment Found</title><link href="http://liverdiseaseinfo.com/liver-diseases/breakthrough-liver-cancer-treatment-2903878a" rel="alternate"></link><updated>2010-10-23T02:52:38Z</updated><author><name>EverydayHealth.com</name></author><id>tag:liverdiseaseinfo.com,2010-10-23:/liver-diseases/breakthrough-liver-cancer-treatment-2903878a/</id><summary type="html">...</summary><category term="Cancer"></category><category term="Colorectal Cancer"></category><category term="Liver Cancer"></category><category term="Internal Medicine"></category><category term="Liver Diseases"></category><category term="Medical Treatments and Procedures"></category><category term="Medical Drug Therapy"></category><category term="Surgery"></category><category term="United States"></category><category term="New York City"></category><category term="Chicago"></category><category term="Africa"></category><category term="Asia"></category><category term="American Cancer Society"></category><category term="Mount Sinai School of Medicine"></category><category term="Wake Forest University"></category><category term="Bayer AG"></category><category term="Sub-Saharan Africa"></category><category term="American Society of Clinical Oncology"></category><category term="Nexavar"></category><category term="Len Lichtenfeld"></category><category term="Baraclude"></category><category term="Chemotherapy"></category><category term="Bernard Nordlinger"></category><category term="Ambroise Pare Hospital"></category><category term="Joseph Llovet"></category><category term="A. William Blackstock"></category></entry></feed>
